Skip Navigation



Annals of Oncology Advance Access published online on May 25, 2008
Annals of Oncology, doi:10.1093/annonc/mdn371
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
19/8/1509    most recent
mdn371v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Necchi, A.
Right arrow Articles by Salvioni, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Necchi, A.
Right arrow Articles by Salvioni, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letter to the editor

Does oxaliplatin and paclitaxel combination show an activity of some extent in pretreated patients with germ-cell tumors?

Reply to the article "A phase II multicenter study of oxaliplatin in combination with paclitaxel in poor prognosis patients who failed cisplatin-based chemotherapy for germ-cell tumors" by C. Theodore et al. (Ann Oncol 2008; doi: 10.1093/annonc/mdn122)

The first 10% of the full text of this article appears below.

We have read with interest the article by Theodore et al. on the results of a combination of oxaliplatin and paclitaxel in a population of pretreated patients (pts) with . . . [Full Text of this Article]

A. Necchi1,*, N. Nicolai2 and R. Salvioni2

1 Department of Medicine, Medical Oncology Unit 3
2 Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

* (E-mail: anynecchi@yahoo.it)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?